FeNO 1+2 is a system that detects, quantifies, and monitors airway inflammation. It's response to pharmacological treatment, therapy, screening, and assessment of Primary Ciliary Dyskinesias (PCD) and accurate measurements of Exhaled Nitric Oxide (NO), bronchial, nasal, and alveolar for early detection and patient management of asthma and inflammation.
Meets all ERS/ATS /CE-IVD guidelines, standardized tests
Easy software-driven testing procedure
Simple, fast, non-invasive measurement with quality control
Lowest cost per test
User-accessible NO sensor, long-lasting, typically 24 months or longer.
Can connect to HIS system
3 TESTING MODES:
Bronchial - FeNO 50 at a flow rate of 50ml/s with incentive screen.
Alveolar - FeNO 200/CaNO with automatic Calv and Jaw graphic generation, at different flow rates of 200ml/s
Nasal - FnNO 5 at a sample flow rate of 10ml/s through a nasal catheter, breathing through resistance for velum closing.
with features Online, Offline, and Tidal modes, allowing for flexible monitoring and assessment of adult, child , and baby
The device can do a "Joint examination of large and small airways and upper and lower airways" 1+2 in one device, and monitor various respiratory diseases, including but not only: